Literature DB >> 18190882

Circadian rhythms in arthritis: hormonal effects on the immune/inflammatory reaction.

Maurizio Cutolo1, Rainer H Straub.   

Abstract

Biological signaling and rhythms occur in a complex network with participation and interaction of the central nervous system, the autonomic nervous system, the endocrine glands, peripheral endocrine tissues and the immune system. It is a clinical observation that patients affected by chronic immune/inflammatory conditions (i.e. rheumatoid arthritis/RA) exhibit circadian, circamensual (females) and circannual rhythms of disease-related symptoms. Proinflammatory cytokines exhibit a peculiar rhythmicity, in particular serum TNF and serum IL-6, and together with other relevant immunological parameters display an elevation in the early morning hours in patients with RA. As a matter of fact, RA patients particularly experience joint pain, morning stiffness, and functional disability in the early morning hours. Since circadian rhythmicity of neuroendocrine pathways is closely coupled to immune/inflammatory reactions, new aspects at least concerning RA management are suggested. In particular, further investigations will indicate whether timed release of immunosuppressive/antiinflammatory drugs will have increased efficacy and whether dosages can be reduced below critical levels above which adverse events appear.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18190882     DOI: 10.1016/j.autrev.2007.11.019

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  32 in total

1.  USP2a protein deubiquitinates and stabilizes the circadian protein CRY1 in response to inflammatory signals.

Authors:  Xin Tong; Katie Buelow; Anirvan Guha; Rebecca Rausch; Lei Yin
Journal:  J Biol Chem       Date:  2012-06-05       Impact factor: 5.157

2.  Morning stiffness of the joints is the sole predictor of short-term response to glucocorticoid treatment in active rheumatoid arthritis (RA).

Authors:  C Fiehn; S Kessler; K Müller
Journal:  Rheumatol Int       Date:  2011-09-21       Impact factor: 2.631

3.  Circadian variations in gene expression in rat abdominal adipose tissue and relationship to physiology.

Authors:  Siddharth Sukumaran; Bai Xue; William J Jusko; Debra C Dubois; Richard R Almon
Journal:  Physiol Genomics       Date:  2010-08-03       Impact factor: 3.107

4.  Relationships between autonomic nerve function and gastric emptying in patients with autoimmune gastritis.

Authors:  Çağdaş Kalkan; Çiğdem Soydal; Elgin Özkan; Ata Maden; Irfan Soykan
Journal:  Clin Auton Res       Date:  2016-04-08       Impact factor: 4.435

Review 5.  Circadian rhythms in leukocyte trafficking.

Authors:  David Druzd; Alba de Juan; Christoph Scheiermann
Journal:  Semin Immunopathol       Date:  2014-01-17       Impact factor: 9.623

6.  The role of the hypothalamic-pituitary-adrenal axis in modulating seasonal changes in immunity.

Authors:  Kamau Pierre; Naomi Schlesinger; Ioannis P Androulakis
Journal:  Physiol Genomics       Date:  2016-06-24       Impact factor: 3.107

7.  Mathematical modeling of the circadian dynamics of the neuroendocrine-immune network in experimentally induced arthritis.

Authors:  R Rao; D DuBois; R Almon; W J Jusko; I P Androulakis
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-05-24       Impact factor: 4.310

8.  Plasma melatonin levels do not differ in SLE patients.

Authors:  P Wang; H-M Li; Y-F Zou; J-H Tao; H-F Pan
Journal:  Z Rheumatol       Date:  2018-02       Impact factor: 1.372

9.  Assessment of the impact of dosing time on the pharmacokinetics/pharmacodynamics of prednisolone.

Authors:  Jian Xu; Julia Winkler; Sreedharan Nair Sabarinath; Hartmut Derendorf
Journal:  AAPS J       Date:  2008-06-25       Impact factor: 4.009

10.  Elevation of Bombina variegata peptide 8 in mice with collagen-induced arthritis.

Authors:  Daitaro Kurosaka; Kentaro Noda; Ken Yoshida; Kazuhiro Furuya; Taro Ukichi; Eigo Takahashi; Maimi Yanagimachi; Isamu Kingetsu; Saburo Saito; Akio Yamada
Journal:  BMC Musculoskelet Disord       Date:  2009-04-30       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.